Latest News

MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products Drug alert number: EL(25)A/21 Date issued: 13 May 2025 Chemidex Pharma Ltd has informed the…

We have updated our Contract changes: DSP regulatory FAQs news item with a new FAQ: Some DSP pharmacies have been planning to deliver the COVID-19…

Ahead of 1st June 2025, pharmacy owners are reminded of the changes to the bundling requirements for Pharmacy First which will impact on whether they…

Pharmacy owners should be aware that the Pharmacy First Clinical Pathways band assignments and monthly caps for May 2025 are published on the NHSBSA website.…

MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited Drug alert number: EL(25)A/20 Date issued: 08 May 2025 Blumont Pharma Limited…

Update 08/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Cefalexin 250mg/5ml oral…

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological…

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on prescription switching. For…